Raleigh-Durham News
Propella Therapeutics Acquired by Astella Pharma in $175 Million Deal
Alcove Tean | 11/16/23
Startup biotech Propella Therapeutics, known for its development of a prostate cancer treatment, is being acquired by Astella Pharma for $175 million.